It’s encouraging that so many biotech and pharmaceutical companies are working on COVID-19 vaccines. Researchers will need a lot of volunteers to run human trials.
Maybe you should participate. Arlene Weintraub profiles the type of person vaccine developers want for trials, along with what to expect if you participate, the chance of getting a placebo and possible side effects.
Record-low mortgage rates
Jacob Passy describes what should be a borrower’s paradise, but is turning out to be a difficult market for home buyers.
Retirement destinations
Silvia Ascarelli helps a woman who wants to retire and move from Maine to Texas, with three possible destinations.
A potential coronavirus medication kept off the market
Gilead’s remdesivir medication is a well-known treatment for people suffering from COVID-19 infections, but Rex Nutting says another Gilead medication may be more effective, at lower cost, but that the company is refusing to test it.
The case for gold …
Above is a chart showing the price of gold relative to the level of the S&P 500 Index over the past 30 years. Gold GC00, +0.89% is relatively cheap against the benchmark index, even after its remarkable rise this year. That is among several reasons Michael Cuggino, CEO of the Permanent Portfolio Family of Funds, believes gold may head to $4,000 an ounce.
Related:Gold is hitting new highs — these are the stocks to consider buying now
… and the case against gold
But Mark Hulbert says gold’s “fundamental value,” adjusted for inflation, is so high right now that it would be foolish for investors to buy.
This man is 52 — should he retire?
Alessandra Malito helps a man in an interesting set of (mostly good) circumstances decide whether early retirement is right for him.
A timely retirement question
What if your parents aren’t prepared for retirement, and time is getting short?
Bringing baggage into a marriage
Quentin Fottrell — MarketWatch’s Moneyist — helps a man whose fiancée is divorced, and worried she may be on the hook for her ex-husband’s $100,000 delinquent tax bill.
A rosy prediction
Michael Brush expects the stock market to be riding high a year from now.
Add Comment